NCT05194735 2025-11-10
Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors
Alaunos Therapeutics
Phase 1/2 Terminated
Alaunos Therapeutics
M.D. Anderson Cancer Center
Fate Therapeutics
University of Michigan Rogel Cancer Center